Imamichi T, Berg S C, Imamichi H, Lopez J C, Metcalf J A, Falloon J, Lane H C
Laboratory of Molecular Retrovirology, Clinical Services Program, SAIC-Frederick, Frederick Cancer Research and Development Center, Frederick, Maryland 21702, USA.
J Virol. 2000 Dec;74(23):10958-64. doi: 10.1128/jvi.74.23.10958-10964.2000.
The combination of an amino acid deletion at codon 67 (delta 67) and Thr-to-Gly change at codon 69 (T69G) in the reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) is associated with high-level resistance to multiple RT inhibitors. To determine the relative contributions of the delta 67 and T69G mutations on viral fitness, we performed a series of studies of HIV replication using recombinant variants. A high-level 3'-azido-3'-deoxythymidine (AZT)-resistant variant containing delta 67 plus T69G/K70R/L74I/K103N/T215F/K219Q in RT replicated as efficiently as wild-type virus (Wt). In contrast, the construct without delta 67 exhibited impaired replication (23% of growth of Wt). A competitive fitness study failed to reveal any differences in replication rates between the delta 67+T69G/K70R/L74I/K103N/T215F/+ ++K219Q mutant and Wt. Evaluation of proviral DNA sequences over a 3-year period in a patient harboring the multiresistant HIV revealed that the T69G mutation emerged in the context of a D67N/K70R/T215F/K219Q mutant backbone prior to appearance of the delta 67 deletion. To assess the impact of this stepwise accumulation of mutations on viral replication, a series of recombinant variants was constructed and analyzed for replication competence. The T69G mutation was found to confer 2',3'-dideoxyinosine resistance at the expense of fitness. Subsequently, the development of the delta 67 deletion led to a virus with improved replication and high-level AZT resistance.
人类免疫缺陷病毒1型(HIV-1)逆转录酶(RT)中密码子67处氨基酸缺失(δ67)与密码子69处苏氨酸到甘氨酸的变化(T69G)相结合,与对多种RT抑制剂的高水平耐药性相关。为了确定δ67和T69G突变对病毒适应性的相对贡献,我们使用重组变体对HIV复制进行了一系列研究。一个在RT中含有δ67加T69G/K70R/L74I/K103N/T215F/K219Q的高水平3'-叠氮-3'-脱氧胸苷(AZT)耐药变体的复制效率与野生型病毒(Wt)一样高。相比之下,没有δ67的构建体复制受损(为Wt生长的23%)。一项竞争性适应性研究未能揭示δ67+T69G/K70R/L74I/K103N/T215F/+++K219Q突变体与Wt之间在复制速率上的任何差异。对一名携带多重耐药HIV患者的前病毒DNA序列进行了为期3年的评估,结果显示T69G突变出现在D67N/K70R/T215F/K219Q突变主干的背景下,早于δ67缺失的出现。为了评估这种突变的逐步积累对病毒复制的影响,构建了一系列重组变体并分析其复制能力。发现T69G突变以适应性为代价赋予对2',3'-二脱氧肌苷的耐药性。随后,δ67缺失的出现导致一种复制能力提高且具有高水平AZT耐药性的病毒。